Nutex Health (US:NUTX) Globenewswire·2025-10-01 18:29Core Viewpoint - Nutex Health Inc. is facing legal scrutiny due to a class-action lawsuit alleging deceptive billing practices aimed at inflating financial results, involving collaboration with a third-party billing firm, HaloMD [1][2]. Group 1: Allegations and Legal Actions - The lawsuit claims Nutex and HaloMD exploited the insurance arbitration process by submitting thousands of questionable claims, falsely certifying their validity to obtain excessive reimbursements [2]. - A report by activist short-seller Blue Orca Capital accused HaloMD of a fraudulent scheme to extract millions from insurers, leading to significant market fallout and a drop in Nutex's stock price by over 10% [3][4]. - The class-action suit seeks damages for investors misled by Nutex's public disclosures during the alleged misrepresentation period [10]. Group 2: Financial Reporting and Internal Controls - Nutex is accused of misrepresenting its progress in addressing internal control deficiencies, particularly in misclassifying stock-based compensation obligations, which distorted its financial position [5]. - Following a delay in submitting its Form 10-Q due to "non-cash accounting adjustments," Nutex's shares fell by 16.39%, closing at $92.91 [6]. - An Audit Committee found that prior financial statements required restatement due to incorrect classification of obligations related to hospital development [7]. Group 3: Investor Response and Investigations - Hagens Berman is investigating the claims against Nutex, focusing on whether the company's business model relied on questionable arbitration tactics and misleading financial reporting [11]. - The firm encourages investors who suffered losses to submit their claims and is examining the potential for recovery [11].